Tablet formulations and uses thereof

TW202635290APending Publication Date: 2026-09-01PASITHEA THERAPEUTICS CORP
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114145609
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-07-30
Filing Date
2025-11-21
Publication Date
2026-09-01

Smart Images

  • Figure TWG2TA001074733_001
    Figure TWG2TA001074733_001
  • Figure TWG2TA001074733_002
    Figure TWG2TA001074733_002
  • Figure TWG2TA001074733_003
    Figure TWG2TA001074733_003
Patent Text Reader

Abstract

Provided are formulations comprising (5R,6S)-10,11-difluoro-12-((2-fluoro-4-iodophenyl) amino)-5,6-dihydroxy-4,5,6,7-tetrahydro-1H-spiro[benzo[b][1,5,4]oxathiazecine-3,1'-cyclopropane] 2,2-dioxide or a pharmaceutically acceptable salt or solid form thereof, methods for treating, preventing and managing diseases or disorders, such as cancer, using the same.
Need to check novelty before this filing date? Find Prior Art